Internal Medicine, Cardiovascular Disease · Houston, TX
NPI
1760449268
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6560 Fannin St Ste 1750
Houston, TX, 77030
Phone (713) 790-0400
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.3M
8,014 services
Medicare patients, 2024
1,319
Average age 75
Drug cost, 2024
$2.6M
13,470 prescriptions
Company payments, 2025
$1,573
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George A Younis was code 99214 (office e&m - established), 1,865 times for 1,090 patients. In total George A Younis billed 8,014 services in 53 codes, and Medicare paid $1.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-03-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,865 | 1,090 | $88.15 | $164K |
| 93000 Electrocardiogram | Office | 1,490 | 1,091 | $9.88 | $15K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 1,212 | 303 | $4.99 | $6,050 |
| 93306 Echocardiography (TTE/TEE) | Office | 496 | 473 | $146.54 | $73K |
| 93015 Electrocardiogram | Office | 321 | 317 | $55.99 | $18K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 306 | 299 | $640.50 | $196K |
| 78431 Myocardial Perfusion Scan | Office | 302 | 299 | $1,874.04 | $566K |
| 78434 Myocardial Perfusion Scan | Office | 301 | 298 | $478.65 | $144K |
| 99204 Office E&M - New | Office | 246 | 246 | $120.25 | $30K |
| 99232 Hospital E&M - Subsequent | Facility | 80 | 42 | $62.72 | $5,017 |
| 93224 Electrocardiogram | Office | 62 | 61 | $49.47 | $3,067 |
| 93229 Electrocardiogram | Office | 61 | 60 | $640.33 | $39K |
| 93228 Electrocardiogram | Office | 61 | 60 | $19.96 | $1,217 |
| 93970 Duplex Scan - Extremity Veins | Office | 60 | 60 | $137.94 | $8,276 |
| 99213 Office E&M - Established | Office | 54 | 54 | $61.67 | $3,330 |
By year: 2022 $850K for 8,019 services; 2023 $1.3M for 8,315 services; 2024 $1.3M for 8,014 services.
Medicare prescription drug claims, 2024
In 2024, the drug George A Younis prescribed most often to Medicare patients was Ezetimibe, with 1,215 prescriptions and refills. In total George A Younis wrote 13,470 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,215 | 2,882 | 410 | $31K |
| Metoprolol Succinate Generic | 1,063 | 2,869 | 326 | $19K |
| Rosuvastatin Calcium Generic | 1,046 | 2,706 | 330 | $17K |
| Atorvastatin Calcium Generic | 881 | 2,396 | 261 | $9,128 |
| Olmesartan Medoxomil Generic | 837 | 2,207 | 252 | $18K |
| Eliquis Apixaban | 763 | 1,533 | 175 | $849K |
| Amlodipine Besylate Generic | 757 | 2,037 | 228 | $5,665 |
| Repatha Sureclick Evolocumab | 506 | 734 | 103 | $405K |
| Torsemide Generic | 331 | 816 | 116 | $4,855 |
| Carvedilol Generic | 320 | 847 | 95 | $3,640 |
| Clopidogrel Clopidogrel Bisulfate | 316 | 861 | 99 | $4,004 |
| Metoprolol Tartrate Generic | 271 | 704 | 77 | $2,366 |
| Losartan Potassium Generic | 263 | 746 | 89 | $3,442 |
| Lisinopril Generic | 261 | 714 | 80 | $2,486 |
| Olmesartan-Hydrochlorothiazide Olmesartan/Hydrochlorothiazide | 249 | 692 | 75 | $11K |
Brand drugs: 2,270 claims; generic drugs: 11,200 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George A Younis $1,573 ($1,573 in general payments such as food, travel and fees) from 11 companies. The largest payer was Boston Scientific Corporation with $436.
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation BSX | 5 | $436 |
| Abbott Laboratories ABT | 3 | $325 |
| Abiomed JNJ | 4 | $296 |
| Amgen Inc. AMGN | 6 | $207 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $103 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $64.04 |
| Baxter Healthcare BAX | 2 | $43.6 |
| Cleerly, Inc. | 1 | $28.78 |
| Novo Nordisk Inc NVO | 1 | $28.31 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $23.39 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.